
Maxime Feyeux
@feyeuxmaxime
#PhD #StemCell #iPS #CellTherapy / Co-founder & CSO of @treefrogtx / Host of the webcast #InTheStemCellJungle
ID: 1339241706898796546
https://stemcelljungle.com/ 16-12-2020 16:12:17
68 Tweet
85 Followers
100 Following

Special thanks to our jury ! #PeterAndrews The University of Sheffield, mahadevan Havard University, Marta Shahbazi @MRC_LMB, Justin Eyquem UC San Francisco, Shin Kawamata kobe_fbri, Pierre Nassoy CNRS 🌍


PR: Umoja Biopharma & TreeFrog Therapeutics announce collaboration in Immuno-Oncology, combining Umoja’s technologies in gene-edited #iPSCs & immune differentiation with TreeFrog’s biomimetic platform for the mass-production of #iPSbasedcelltherapies in bioreactors. treefrog.fr/umoja-biopharm…


Excited to make this first step in immuno-oncology with Umoja Biopharma ! What a team !


Press Release : 10 international scientists nominated for the $100,000 Stem Cell SpaceShot Grant ! treefrog.fr/10-internation… Nominees are from UC San Diego Health King's College London RIKEN Institut Curie Cambridge University Case Western Reserve VUB University Health Network U of Saskatchewan TMDU - Tokyo Medical and Dental University


Choosing 10 nominees for the Stem Cell SpaceShot Grant : feedback from Maxime Feyeux , PhD, co-founder and chief scientific officer of TreeFrog Therapeutics. Learn more about the nominees : treefrog.fr/10-internation… Learn more about the grant : treefrog.fr/stem-cell-spac…

Why this wave of allogeneic cell therapy programs in oncology with biotechs ? I asked Neil Sheppard D.Phil., Head of the T cell engineering lab at Penn. He pointed out exciting trials by Caribou Biosciences and Allogene Therapeutics Full #InTheStemCellJungle episode : lnkd.in/e94cD9eS

#TME #CARTs: What about T cell-based strategies in solid tumors like TIL (Iovance Biotherapeutics) & TCR-T (Adaptimmune, @immatics) therapies ? I asked Neil Sheppard D.Phil, Adjunct Associate Prof., head of the TCEL at Penn #InTheStemCellJungle >> youtube.com/watch?v=hOfZBp…

#PR Breakthrough technology for #iPS-based #CellTherapies turned into #GMP platform by TreeFrog Therapeutics & Invetech ! treefrog.fr/treefrog-thera… Next : Transfer to CDMO in 2023 (TreeFrog's trial in Parkinson's) + 3 additional machines to support pipeline in immuno-oncology & #RegMed


TreeFrog dans le #FT120 ! Quelle trajectoire ? Quels jalons Ă venir ? Quel impact en France ? 2 min avec Jean-Luc TREILLOU, co-fondateur de TreeFrog Therapeutics. Bienvenue aux nouveaux entrants dans le FrenchTech120, et un grand merci Ă La French Tech !


What can the human body đź§Ť teach us about how to scale up high-quality #pluripotent stem cells (PSCs)? Join us for a live webinar on March 7, with Dr. Maxime Feyeux (Maxime Feyeux), co-founder of TreeFrog Therapeutics (TreeFrog Therapeutics), to find out. bit.ly/3YVjMiw


Happening live TOMORROW! ⚠️ This is your last chance to sign for this webinar on #pluripotent stem cells with Dr. Maxime Feyeux (Maxime Feyeux): bit.ly/3YVjMiw

New publication demonstrating almost 300-fold #hiPSC expansion in 10L #bioreactors within 1 week with #CStem biomimetic platform with high reproducibility & preservation of cell quality. treefrog.fr/exponential-hi… ISSCR ISCT FSSCR 日本再生医療ĺ¦äĽš ESGCT Alliance for Regenerative Medicine (ARM)



The TreeFrog Therapeutics alginate encapsulation system efficiency could be due to its ability to recapitulate in capsulo a 3D lumenized colony that morphologically resembles an epiblast rosette, and which has higher cell viability than 2D colonies. sciencedirect.com/science/articl…

